The U.S. Navy is exploring arming warships with Patriot missiles while Iran tensions disrupt Strait of Hormuz shipping and pharmaceutical supplies.
Hong Kong has overtaken Switzerland as the world's leading cross-border wealth management center, driven by strengthening ties with China.
Interior Secretary Doug Burgum met with Venezuelan officials to explore potential collaboration on oil production and critical mineral extraction.
President Trump signed an executive order directing creation of a nationwide voter verification list, drawing immediate threats of lawsuits from voting rights groups.
Morgan Stanley increased its S&P 500 year-end target to 8,300, citing expectations for strong corporate earnings growth.
The International Energy Agency is reportedly considering recommending the release of a record 400 million barrels from strategic reserves.
Los Angeles City Council member Nithya Raman has moved into second place in the mayoral primary, overtaking Spencer Pratt with vote counting ongoing.
Multiple economic and political developments emerged including US inflation expectations, ECB monetary policy decisions, and election results in Peru.
G7 leaders will convene to address escalating diplomatic tensions with Iran while considering coordinated release of emergency oil reserves.
The Senate held multiple votes on Friday morning involving immigration funding and FISA surveillance powers, with mixed results.
Trade court judge ruled companies must receive refunds for tariffs struck down by Supreme Court, potentially totaling $175 billion.
Maritime tracking data indicates that only ships with connections to Iran are currently transiting through the Strait of Hormuz.
Anthropic announced Project Glasswing, using its unreleased AI model Claude Mythos Preview to find vulnerabilities for major tech companies while restricting public access.
A California federal judge granted Anthropic a temporary injunction blocking the Trump administration from designating the AI company as a supply chain risk.
Eli Lilly reported that participants in a late-stage trial of retatrutide lost an average of 28% of their body weight after 80 weeks of treatment.
Page 55 of 732 (10979 stories)